Siirry sisältöön
Optomed
  • About us
    • Column1
    • ABOUT US
    • Optomed’s story
    • News and events
    • Column2
    • Hidden row
    • Corporate Responsibility
    • Research and Development
    • IPR
    • Column3
    • Hidden row
    • Management
    • Careers
  • Products & Solutions
    • Column1
    • FOR PROFESSIONALS
    • Eye Screening
    • Neurology
    • Pediatrics
    • VET
    • Column2
    • HANDHELD CAMERAS
    • Optomed Lumo
    • Optomed Aurora IQ
    • Optomed Aurora AEYE
    • Smartscope PRO
    • Hidden row
    • DESKTOP CAMERAS
    • Optomed Polaris
    • Column3
    • OPHTHALMOLOGY SOLUTIONS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Flow
    • Avenue Telemedicine
    • Column4
    • OTHER SOLUTIONS
    • Cancer Screening
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
  • Customers
    • Column1
    • CUSTOMERS
    • Testimonials
    • Column2
    • Hidden row
    • Clinical evidence
    • Column3
    • Hidden row
    • Scientific Advisory Board
  • Investors
    • Column1
    • INVESTORS
    • Investors homepage
    • Optomed as an investment
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • Column2
    • Hidden row
    • Investor relations
    • Releases and publications
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • Analysts
    • Column3
    • Hidden row
    • Shares and shareholders
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR calendar
    • Investor events
    • Column4
    • Hidden row
    • Corporate Governance
    • Hidden row
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Column5
    • Hidden row
    • Hidden row
    • Hidden row
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • IPO 2019
  • Contact
    • Column1
    • CONTACT US
    • Contact information
    • Column2
    • Hidden row
    • Where to buy
    • Column3
    • Hidden row
    • Support contact
    • Column4
    • Hidden row
    • Media
  • About us
    • Column1
    • Optomed’s story
    • News and events
    • Corporate Responsibility
    • Research and Development
    • IPR
    • Management
    • Careers
  • Products & Solutions
    • Column1
    • FOR PROFESSIONALS
    • Eye Screening
    • Neurology
    • Pediatrics
    • VET
    • HANDHELD CAMERAS
    • Optomed Lumo
    • Optomed Aurora IQ
    • Optomed Aurora AEYE
    • Smartscope PRO
    • DESKTOP CAMERAS
    • Optomed Polaris
    • OPHTHALMOLOGY SOLUTIONS
    • Avenue AI
    • Avenue Eye Screen
    • Avenue Flow
    • Avenue Telemedicine
    • OTHER SOLUTIONS
    • Cancer Screening
    • Radiology
    • Optomed Radiology Information System (RIS)
    • Sectra PACS
    • Optomed Service Portal
    • Cephalometry
    • Pathology
  • Customers
    • Column1
    • Testimonials
    • Clinical evidence
    • Scientific Advisory Board
  • Investors
    • Column1
    • Investors homepage
    • Optomed as an investment
    • Key figures
    • Business model
    • Markets
    • Strategy
    • Mission and values
    • Future outlook
    • Financial targets and dividend policy
    • Corporate Responsibility
    • Column2
    • Investor relations
    • Releases and publications
    • Annual reports
    • Financial reports and presentations
    • Interviews
    • Analysts
    • Column3
    • Shares and shareholders
    • Management transactions
    • Shareholders
    • Share monitor
    • Flagging notifications
    • Option Programs
    • Authorizations
    • IR calendar
    • Investor events
    • Column4
    • Corporate governance
    • General Meeting
    • Previous General Meetings
    • Statements and Reports
    • Articles of association
    • Board of Directors
    • Committees
    • Shareholders’ Nomination Board
    • CEO and Leadership Team
    • Remuneration
    • Risk management
    • Insider management
    • External Auditor
    • Disclosure policy
    • Related party transactions
    • IPO 2019
  • Contact
    • Column1
    • Contact information
    • Where to buy
    • Support contact
    • For Media
Optomed | Interim Report for 1 January – 31 March 2024
Back
Jaa Facebookissa Jaa Twitterissä Jaa LinkedInissä Jaa WhatsAppissa
Support Contact Privacy statement Whistleblow Whistleblow instructions
  • FacebookFacebook
  • TwitterTwitter
  • YouTubeYouTube
  • LinkedInLinkedIn

Optomed is a Valued Supplier on the IAPB Standard List

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

Our camera products have medical approvals in all key markets, including CE (Europe) and FDA (USA), and CFDA (China).

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy and Cookie Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked. Accept AllCustomize
Privacy & Cookies Policy

Privacy Overview

We use cookies for analytics to improve your experience with us. To find out more, have a look at our Privacy Policy. If you decline, your information won't be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Save & Accept